43% of new cases are in three states of Maharashtra, Andhra Pradesh and Karnataka


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ 43% of new cases are in three states of Maharashtra, Andhra Pradesh and Karnataka
Nearly half of active cases are only from 3 states

Seven States have contributed to 70% of these new cases in the last 24 hours. Of these, Maharashtra has contributed the maximum case load amounting to almost 21%, followed by Andhra Pradesh (13.5%), Karnataka (11.27%) and Tamil Nadu which stands at 8.27%.

Uttar Pradesh with 8.27%, West Bengal with 3.85%, and Odisha with 3.84% are the remaining States contributing to the increased caseload. Of the total cumulative number of cases, 43% are recorded in just three states of Maharashtra, Andhra Pradesh and Karnataka.

While Tamil Nadu has contributed 11.66% of the total cases. Maharashtra, Andhra Pradesh and Karnataka account for about 50% of the deaths added in the last 24 hours due to COVID-19, with Maharashtra leading with 30.48%.The Union Government yesterday said that the COVID-19 recovery rate in the country has reached 76.61 per cent. Around 60,868 people recovered from the infection during the last 24 hours.

The Health Ministry said, the total number of recoveries has reached over 27 lakh 74 thousand so far.

The Ministry said, the last five lakh recoveries have been recorded in only eight days.

The constantly increasing recoveries have ensured reduction in the actual caseload of the country and it now comprises only 21.60 per cent of the total positive cases.Currently, India’s Case Fatality Rate is at 1.79 per cent, which is one of the lowest globally.

According to Indian Council of Medical Research, over 8,46000 tests were conducted during the last 24 hours. The total number of samples tested so far has gone up to over 4 crore 23 lakhs.

Meanwhile,  Japan has committed an official Development Assistance loan of 3500 crore rupees for the COVID-19 Crisis Emergency Response Support. The Notes were exchanged between the Additional Secretary in the Department of Economic Affairs Dr C.S. Mohapatra and Ambassador of Japan to India Suzuki Satoshi for a Health sector programme loan to fight the COVID-19 crisis.

Subsequent to the Exchange of Notes, Loan Agreement for the programme loan was signed between Dr Mohapatra and Chief Representative of JICA in New Delhi Katsuo Matsumoto.

Japan International Cooperation Agency, JICA is a governmental agency that coordinates Official Development Assistance for the Government of Japan.

This programme loan aims to support India’s efforts in fighting COVID-19 and to prepare the health system to manage future epidemics and also to improve the resilience of India’s health systems against infectious diseases.

Notes were also exchanged between Dr. Mohapatra and Mr Satoshi for Grant Assistance of 70 crore rupees from the Government of Japan.

This Grant-in-aid from the Government of Japan is for providing medical equipment to strengthen the public health and medical system in India. It will strengthen the health care facilities for managing critical and serious patients suffering from COVID-19 infection.

India and Japan have had a long and fruitful history of bilateral development cooperation since 1958. In the last few years, the economic cooperation between India and Japan has strengthened and grown into strategic partnership. It further consolidates and strengthens the Strategic and Global Partnership between India and Japan.

Tags : #IndiaNewCovidCases #JapanCovidAssistance #IndiaCovidNewsUpdateSep1 #IndiaCovidStatusSep1 #JICA #CaseFatalityRate #SuzukiSatoshi

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Clinical Interventions in Chronic Hepatitis B and C: Antiviral Efficacy, Liver Fibrosis Scoring, and Monitoring August 11, 2026
Common Health Mistakes Indians Should Avoid: A Practical Guide to Everyday WellnessAugust 11, 2026
How to Build a Healthy Lifestyle After 40: A Practical Guide for Indian AdultsAugust 11, 2026
Milk Microbiome Could Hold New Clues to Lifelong Health, Experts SayAugust 10, 2026
Globally Renowned Dermatologist and Sesderma Founder Professor Dr. Gabriel Serrano to Visit India to Showcase Cutting-Edge Derma-Tech for Indian Skincare at Scientific Symposiums Hosted by Iberia PharmaceuticalsAugust 10, 2026
Sharda Hospital Celebrates World Breastfeeding Week with a Week-Long Awareness ProgrammeAugust 10, 2026
Swinburne University of Technology Opens Applications for Master of Engineering ScienceAugust 10, 2026
GLP-1 Receptor Agonists: A New Era in Weight Loss TreatmentAugust 10, 2026
Immunotherapy vs. Chemotherapy: Understanding the Mechanisms of Precision OncologyAugust 10, 2026
Mitigating Tech-Induced Ailments: Managing Screen Time, Sedentary Lifestyles, and Dry Eye SyndromeAugust 10, 2026
The Blueprint of Validation: Navigating Medical AI’s "Reckoning Year"August 10, 2026
The Future of Smart Hospitals: Redefining Healthcare Delivery in India August 10, 2026
Healthcare Data Security in India: Risks, Threats, and Best Practices for a Digital-First Health EcosystemAugust 10, 2026
The Science of Resilience: Psychological Strategies for Modern StressAugust 08, 2026
The Science of Fasting: 2026 Research on Autophagy and LongevityAugust 08, 2026
Early Markers of Insulin Resistance: Moving Beyond Fasting Blood SugarAugust 08, 2026
Healthcare Management Challenges in India: What Hospital Leaders Must Address NowAugust 08, 2026
Importance of Patient Safety: Why Every Hospital in India Must Prioritize ItAugust 08, 2026
Decoding Fatty Liver Disease: Symptoms, Reversibility, and the MASLD/NAFLD SpectrumAugust 07, 2026
Heart-Healthy Dietary Patterns: Translating Clinical Nutrition Guidelines into Daily MealsAugust 07, 2026